Search Results - "Kawalec, P."

Direct Costs Of Diabetes Mellitus In Poland by Kawalec, P

Get full text

Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland by Kawalec, P

Get full text

Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis by Kawalec, P., Holko, P., Moćko, P., Pilc, A.

“…To assess the comparative effectiveness and safety of novel biologic therapies in psoriatic arthritis (PsA) and to establish the position of the non-anti-tumor…”
Get full text

The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland by Mocko, P, Kawalec, P

Get full text

Costs of Absenteeism In Psoriatic and Enteropathic Arthropathies Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012 by Kawalec, P, Malinowski, K

Get full text

Costs of Absenteeism In Ankylosing Spondylitis Based On Real-Life Data From Poland's Social Insurance Institution Database In 2012 by Malinowski, K, Kawalec, P

Get full text

The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland by Kawalec, Paweł P, Malinowski, Krzysztof P

“…Systemic lupus erythematosus, systemic sclerosis and sarcoidosis are three different autoimmune systemic diseases that generate a significant burden to society…”
Get more information

Heavy metals in soil affect reproductive processes more than morphological characters in Viola tricolor by Słomka, A., Jędrzejczyk-Korycińska, M., Rostański, A., Karcz, J., Kawalec, P., Kuta, E.

“…► Metalliferous and nonmetalliferous populations of Viola tricolor are not morphologically distinguished. ► Minor influence of environmental conditions on…”
Get full text

Cost-Utility Analysis Of Hypertensive Treatment With Indapamide And Amlodipine Single-Pill Combination In The Polish Setting by Stawowczyk, E, Holko, P, Kawalec, P, Borowiec, L, Filipiak, K.J

Get full text

Budget Impact Analysis Of Hypertensive Treatment With Indapamide And Amlodipine Single-Pill Combination In The Polish Setting by Kawalec, P, Stawowczyk, E, Holko, P, Borowiec, L, Filipiak, K.J

Get full text

PND44 Cost-Utility Analysis and Cost-Minimisation Analysis of Sabril® (Vigabatrin) in Drug-Resistant Epilepsy From Payer's Perspective in Poland by Kawalec, P, Holko, P, Lis, J, Glasek, M

Get full text

Disease Activity, Quality of Life And Indirect Costs Associated With Ulcerative Colitis In Poland by Kawalec, P

Get full text

Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC) by Kawalec, P

Get full text

PCN3 - Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC) by Kawalec, P

Get full text

PCN4 - Tyrosine Kinase Inhibitors (TKI) For The Treatment of Advanced Medullary Thyroid Carcinoma: A Systematic Review and Indirect Comparison by Kawalec, P

Get full text

PSY60 - Disease Activity, Quality of Life And Indirect Costs Associated With Ulcerative Colitis In Poland by Kawalec, P

Get full text

Tyrosine Kinase Inhibitors (TKI) For The Treatment of Advanced Medullary Thyroid Carcinoma: A Systematic Review and Indirect Comparison by Kawalec, P

Get full text

CO70 Comparative Bayesian Network Meta-Analysis of BTKi-Specific Adverse Events in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia by Monica, M., Reczek, M., Kawalec, P.

Get full text

PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in Poland by Kawalec, P, Holko, P, Boratynska, M, Glyda, M, Ignacak, E, Russel-Szymczyk, M, Szkultecka-Sebek, M, Kaweczynska-Lason, A

Get full text

Recommendations and Reimbursement Status of Orphan Drugs In Ue Countries by Kawalec, P

Get full text